Gsk (GSK) Income towards Parent Company (2009 - 2026)

Gsk's Income towards Parent Company history runs 18 years deep, the most recent figure standing at $583.6 million for Q2 2026.

• In Q2 2026, Income towards Parent Company fell 69.68% year-over-year to $583.6 million; the TTM figure through Jun 2026 stood at $9.7 billion (up 44.16% YoY), while the FY2025 annual figure was $7.5 billion, up 128.97% from the prior year.
• Income towards Parent Company for Q2 2026 stood at $583.6 million, down from $2.3 billion in the prior quarter.
• The five-year high for Income towards Parent Company was $17.5 billion in Q4 2022, with the low at -$75.4 million in Q3 2024.
• The 5-year median for Income towards Parent Company is $2.0 billion (2023), against an average of $3.5 billion.
• The sharpest annual moves came in 2024 and 2025: Income towards Parent Company sank 104.06% in 2024, then soared 3704.42% in 2025.
• Gsk's Income towards Parent Company stood at $17.5 billion in 2022, then slumped by 77.97% to $3.9 billion in 2023, then fell by 26.31% to $2.8 billion in 2024, then surged by 43.24% to $4.1 billion in 2025, then sank by 85.69% to $583.6 million in 2026.
• Business Quant data shows GSK's Income towards Parent Company at $583.6 million in Q2 2026, $2.3 billion in Q1 2026, and $4.1 billion in Q4 2025.